Hemorrhagic and Non-hemorrhagic Pituitary Apoplexy: Imaging Cohort Analysis
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 12, Issue 5
Abstract
Introduction: Patients suffering from pituitary apoplexy present with variable clinical symptoms and imaging findings. Imaging findings may differ between hemorrhagic and non-hemorrhagic apoplexy. Our study aimed to better define imaging findings in both hemorrhagic and non-hemorrhagic apoplexy and is the first cohort study to report a comparison of imaging findings in these two groups. Materials and Methods: 311 consecutive patients admitted with pituitary tumors were retrospectively reviewed for clinical and imaging evidence of pituitary apoplexy. 37 operative cases were included in this cohort. A cohort statistical analysis was performed between the two groups using Chi Square, Fisher exact test, logistic regression, ANOVA, and t-test. Results: Imaging analysis demonstrated a significant difference in the hemorrhagic cohort’s Computed Tomography (CT) finding of hyperdensity within the sella (n = 17, 48.5%, p = 0.02) and sellar Hounsfield units (mean 45 versus 38.1, p=0.05). Sellar HU were higher in the hemorrhagic pituitary apoplexy cohort. Similarly, hyperintensity on magnetic resonance imaging was more indicative of patients with hemorrhagic apoplexy according to T1 (p = 0.004), T2 (p = 0.004), and FLAIR (p = 0.04) imaging sequences. No difference was found in patterns of enhancement (p = 0.69) or restriction based on diffusion-weighted imaging (p = 0.54). Gradient echo (n=4) and susceptibility weighted imaging (n=1), while not performed in all patients, demonstrated hemorrhage within a pituitary adenoma in patients where this technique was used. Conclusions: Our study did not demonstrate a unifying imaging feature in non-hemorrhagic apoplexy cases. Hemorrhagic apoplexy was more likely associated with hyperdensity on CT and hyperintensity on T1, T2 and FLAIR MRI sequences. Because of the variation of imaging findings in hemorrhagic and especially non-hemorrhagic apoplexy, imaging appearance inconsistent with hemorrhage should not be used to exclude the diagnosis of apoplexy.
Authors and Affiliations
Esther Dupépé, Joseph H. Miller, Daxa Patel, Don E. McCormick, Soni Srivastav, T. Brooks Vaughan III, Kristen O. Riley
Keywords
Related Articles
- EP ID EP340425
- DOI 10.9734/BJMMR/2016/22132
- Views 50
- Downloads 0
Low Concentration DMSO Stimulates Cell Growth and In vitro Transformation of Human Multiple Myeloma Cells
Aims: To evaluate the effect of Dimethyl sulfoxide (DMSO) on multiple myeloma (MM) cells. Study Design: Experimental study. Place and Duration of Study: Department of Pathology and Genomic Medicine, the Methodist Hospita...
Malignant Mesothelioma vs. Reactive Mesothelial Proliferations: Immunohistochemical Profile
Aims: To examine the distribution of immunohistochemical markers GLUT-1, EMA (membrane epithelial antigen) and Ki-67 in benign and malignant mesothelial lesions. Thus, the sensitivity, specificity, positive and negative...
Vitamin D Receptor fok I Gene Polymorphism in Angiographically Proven Coronary Artery Disease Subjects: Case - Control Study
Aims: Coronary artery disease (CAD) is multifactorial disease resulting from modifiable and non modifiable risk factors. Gene polymorphism is one of the non modifiable risk factors, which may contribute to disease suscep...
The Inductive Effect of Purified Streptococcal M-protein on Immunity against Streptococcus pyogenes in Rabbit Model
Aims: The study aimed to know the effects of the purified M-protein on immune system to produce protection against Streptococcus pyogenes in rabbits. Study Design: Case-control study. Place and Duration of Study: In this...
Quality of Life in Patients with Chronic Kidney Disease: A Cross-sectional Study Comparing Patients on Hemodialysis, Peritoneal Dialysis and with Kidney Transplantation
Aims: The methods of renal replacement therapy influence highly the quality of life (QOL) of patients with chronic kidney disease. The present study aimed to evaluate and compare the QOL in patients undergoing hemodialys...